The Valley Desk

Clinical trial reportInternational journal of radiation oncology, biology, physicsPublished

PREVLAR: Phase 2a Randomized Trial to Assess the Safety and Efficacy of RRx-001 in the Attenuation of Oral Mucositis in Patients Receiving Head and Neck Chemoradiotherapy

Read the publication ↗

Regional connection

Verified An author affiliation on the Europe PMC record names Thomas Jefferson University. Affiliation source

Publication record

Type
Clinical trial report
Venue
International journal of radiation oncology, biology, physics
Published
Subject terms
Humans; Head and Neck Neoplasms; Stomatitis; Nitro Compounds; Azetidines; Chemoradiotherapy
PubMed ID
36646388
Added to directory
Source checked

Report a correction or request removal